These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 20039878)

  • 1. Penitentiary or penthouse condo: the tuberculous granuloma from the microbe's point of view.
    Paige C; Bishai WR
    Cell Microbiol; 2010 Mar; 12(3):301-9. PubMed ID: 20039878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of pathogenic mycobacteria with the host immune system.
    Houben EN; Nguyen L; Pieters J
    Curr Opin Microbiol; 2006 Feb; 9(1):76-85. PubMed ID: 16406837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Host innate and Th1 responses and the bacterial factors that control Mycobacterium tuberculosis infection.
    Salgame P
    Curr Opin Immunol; 2005 Aug; 17(4):374-80. PubMed ID: 15963709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "The very pulse of the machine": the tuberculous granuloma in motion.
    Davis JM; Ramakrishnan L
    Immunity; 2008 Feb; 28(2):146-8. PubMed ID: 18275827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Requisite role for complement C5 and the C5a receptor in granulomatous response to mycobacterial glycolipid trehalose 6,6'-dimycolate.
    Borders CW; Courtney A; Ronen K; Pilar Laborde-Lahoz M; Guidry TV; Hwang SA; Olsen M; Hunter RL; Hollmann TJ; Wetsel RA; Actor JK
    Scand J Immunol; 2005 Aug; 62(2):123-30. PubMed ID: 16101818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Host-directed therapy targeting the Mycobacterium tuberculosis granuloma: a review.
    Kiran D; Podell BK; Chambers M; Basaraba RJ
    Semin Immunopathol; 2016 Mar; 38(2):167-83. PubMed ID: 26510950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Floating between the poles of pathology and protection: can we pin down the granuloma in tuberculosis?
    Reece ST; Kaufmann SH
    Curr Opin Microbiol; 2012 Feb; 15(1):63-70. PubMed ID: 22074861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the tuberculous granuloma in murine and human lungs: cellular composition and relative tissue oxygen tension.
    Tsai MC; Chakravarty S; Zhu G; Xu J; Tanaka K; Koch C; Tufariello J; Flynn J; Chan J
    Cell Microbiol; 2006 Feb; 8(2):218-32. PubMed ID: 16441433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adventures within the speckled band: heterogeneity, angiogenesis, and balanced inflammation in the tuberculous granuloma.
    Matty MA; Roca FJ; Cronan MR; Tobin DM
    Immunol Rev; 2015 Mar; 264(1):276-87. PubMed ID: 25703566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor alpha in mycobacterial infection.
    Dorhoi A; Kaufmann SH
    Semin Immunol; 2014 Jun; 26(3):203-9. PubMed ID: 24819298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune-mediated adverse effects of biologicals used in the treatment of rheumatic diseases.
    Borchers AT; Leibushor N; Cheema GS; Naguwa SM; Gershwin ME
    J Autoimmun; 2011 Dec; 37(4):273-88. PubMed ID: 21907543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of host and microbial determinants in individuals with latent tuberculosis infection using a human granuloma model.
    Guirado E; Mbawuike U; Keiser TL; Arcos J; Azad AK; Wang SH; Schlesinger LS
    mBio; 2015 Feb; 6(1):e02537-14. PubMed ID: 25691598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mycobacterium tuberculosis virulence factors and its immune evasion mechanisms].
    Colakoğlu S
    Mikrobiyol Bul; 2004; 38(1-2):155-67. PubMed ID: 15293916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying control mechanisms of granuloma formation during M. tuberculosis infection using an agent-based model.
    Segovia-Juarez JL; Ganguli S; Kirschner D
    J Theor Biol; 2004 Dec; 231(3):357-76. PubMed ID: 15501468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Who puts the tubercle in tuberculosis?
    Russell DG
    Nat Rev Microbiol; 2007 Jan; 5(1):39-47. PubMed ID: 17160001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An in vitro dual model of mycobacterial granulomas to investigate the molecular interactions between mycobacteria and human host cells.
    Puissegur MP; Botanch C; Duteyrat JL; Delsol G; Caratero C; Altare F
    Cell Microbiol; 2004 May; 6(5):423-33. PubMed ID: 15056213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of Mycobacterium tuberculosis with the host: consequences for vaccine development.
    Dietrich J; Doherty TM
    APMIS; 2009 May; 117(5-6):440-57. PubMed ID: 19400867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.